J. Louhija et al., AGING AND GENETIC-VARIATION OF PLASMA APOLIPOPROTEINS - RELATIVE LOSSOF THE APOLIPOPROTEIN E4 PHENOTYPE IN CENTENARIANS, Arteriosclerosis and thrombosis, 14(7), 1994, pp. 1084-1089
We determined the common polymorphism of apolipoprotein E (E2, E3, and
E4), apolipoprotein B Xba I polymorphism, and apolipoprotein C-III Ss
t I polymorphism in almost all Finnish centenarians alive in 1991 (n=1
79/185). Plasma lipid and lipoprotein levels in different apolipoprote
in genotypes were also measured. In comparison with younger Finnish po
pulations studied previously, the frequency of the apolipoprotein E ep
silon 2 allele was almost twice as high (7.0% versus 4.1%; P<.05) and
that of the epsilon 4 allele only approximately one third as high (8.4
% versus 22.7%; P<.001) in the centenarians. Plasma cholesterol and hi
gh-density lipoprotein cholesterol levels tended to be lowest in the g
roup with the epsilon 2 allele (4.33 mmol/L and 1.41 mmol/L, respectiv
ely), intermediate in those with the epsilon 3 allele (4.57 mmol/L and
1.48 mmol/L, respectively), and highest in those with the epsilon 4 a
llele (4.82 mmol/L and 1.60 mmol/L, respectively). The frequencies of
the apolipoprotein B X1 and X2 alleles (Xba I restriction site absent
or present, respectively) among the centenarians and among the young F
inns were not significantly different, whereas the apolipoprotein C-II
I S2 allele (Sst I restriction site present) occurred more often in th
e centenarians (frequency, 12.9%) than in the youngest reference popul
ation (frequency, 8.8%; P<.05). Centenarians with the apolipoprotein B
X2X2 genotype and apolipoprotein E4 phenotype had a higher mean plasm
a cholesterol level than those with the X1X1 genotype and E2 phenotype
(5.24 versus 3.43 mmol/L; P<.05). We conclude that genetic variation
of apolipoproteins influences blood lipid levels up to very high ages
and that the epsilon 4 allele may affect life expectancy adversely.